Shares in Wearable Health Solutions, Inc. (OTC Pink: WHSI, $WHSI) have been on fire, soaring by more than 75% since June. And the better news, at least for those invested, is that the spike higher is likely the precursor of better moves to come. Why? Because despite $WHSI’s micro-cap size, they are playing in the big leagues when it comes to bringing innovative and technologically advanced wearable medical devices to the markets. Better still, they have the right products to turn its potentially best-in-class wearable products arsenal into a revenue-generating juggernaut.
And in a more than $960 billion market by 2030, that detail matters. In fact, while other companies in the sector are running on “potentially” bringing innovative wearable devices to the markets, WHSI already is, which is the likely reason for investors taking an interest in a disconnect that appreciably discounts the company’s already impressive products portfolio from its stock price. They may be wise to do so. Timely, too.
WHSI’s product lineup includes a stable of wearable medical monitoring devices that are easy to use, remote monitoring capable, embedded with personal emergency response systems, and adaptable, intelligent, and reliable. In other words, they have more than everything a user needs to manage personal health; they are ideally positioned and capable of driving near and long-term revenue streams significantly higher.
Best-In-Class Wearable Devices Expose Opportunity
It’s a likely scenario. Better still, this roughly $0.014 share stock proves it can compete with the industry’s most prominent players with a suite of wearable devices so good that they are considered among the most advanced personal health and safety monitoring devices available. That’s no exaggeration, either. In fact, its wearable devices have been referred to as “exceptional” by even the most critical reviewers.
That evaluation makes sense after considering that WHSI’s small and powerful devices provide best in class personal security with features and functions including tracking, fall detection, medication reminders, email and text alerts, google and amazon assistant compatibility, and programming to support any language. That list already surpasses competing product abilities. But, WHSI’s products do much more.
Wearable Health Solutions’ compact devices also allow individuals to collect and share essential vital signs, including blood pressure, oxygen levels, and temperature, in real-time utilizing Bluetooth technology. Of course, checking those boxes is necessary and even life-saving. What’s more, it exposes that in a sector where product quality matters more than company size, WHSI could be a shining star in the booming industry. Thus, don’t be fooled by its micro-cap price. The intrinsic and inherent value for a more appropriately priced WHSI stock has not been priced into the stock. Still, that gap could close quickly. And it likely will, with the rally attracting new attention.
Moreover, those new to the WHSI opportunity see that the company has laid the groundwork to capitalize on a medical wearables market that offers massive revenue-generating potential in 2022. That’s excellent news today. However, with an almost $1 trillion opportunity by 2030, the best for WHSI and its investors may be yet to come.
Right Products To Meet Surging Demand
That’s a probable assumption, noting that WHSI isn’t speculating on hoped-for demand but instead meeting it head-on. And that timeliness sets up Wearable Health Solutions, Inc. to have its most productive year in history and carry considerable operating momentum into 2023 by maximizing new and aggressive marketing and potential licensing initiatives.
Keep in mind that even the most ambitious revenue models may prove conservative. Remember, with patients needing and wanting what WHSI is selling, targeting a significant part of the already multi-billion dollar market opportunity is already in the crosshairs. And WHSI can earn an appreciable share of a market still in development by executing its marketing mission.
Still, products may be just one value driver this year. WHSI announced completing the audits required to uplist, which could, when completed, add considerable value to its share price. If WHSI can combine uplist news with positive marketing and revenue updates, the result could be multiplied, with WHSI stock potentially ripping higher by exponential measures. Still, meeting just the latter could send stock prices soaring.
Mobile Health Solutions At The Right Time
And the excellent news on all fronts is that WHSI isn’t taking its time to monetize opportunities. Instead, they are working to unleash the value inherent to its mobile health solutions products by integrating cutting-edge technology, providing users real-time information that can be seamlessly transmitted to family and healthcare providers. It’s a capability attractive to users because it allows for a sense of freedom for patients, with embedded device technology and transmission allowing patients to transmit data from virtually anywhere and at any time. Those differences are significant advantages. Preferences, too.
Not only that, Wearable Health Solutions’ current products arsenal, and those in development, are more than dependable; they are among the most comprehensive devices on the market, with advanced features eliminating restrictive daily routines and providing a better quality of life. Thus, there’s plenty of incentive for users and marketers to migrate toward WHSI solutions.
Indeed, that’s potentially excellent news for investors as well. More so because they aren’t investing in a wait-and-see proposition. Instead, they take advantage of a company seizing upon a massive revenue-generating opportunity with an expert team to navigate growth. Of course, products and platforms matter, and WHSI has plenty to offer.
iHelp Max 4G Monitors In Fashion
Leading the charge could be its one-stop-shop of services, WHSI’s iHelp Max 4G monitor. And it could address several needs simultaneously. How? By delivering countless user-centric features that streamline the healthcare experience through a wearable monitor that includes powerful software innovations and hardware technology to provide users with an all-encompassing healthcare management solution. And by delivering best-in-class capability through a compact design, its chance of user and prescriber favor is significantly increased.
Other factors strengthen that presumption. Its “smart” enabled iHelp Max 4G monitor is compatible with both Amazon Alexa and Google Assistant, can respond to voice commands, facilitates connectivity to supporting mobile apps, and is equipped with Bluetooth technology to transmit data in real-time. There’s still more to like and more to justify the investment consideration for investors.
By utilizing modern wireless technologies, the iHelp Max 4G can measure and transmit data on the go, with additional features including GPS location, fall detection, and medication management. And with features compatible with everyday home tech, the iHelp Max 4G can be added seamlessly to existing communication technology. Checking the competition, many brands can’t say the same, and those that can may be missing another critical element- connectivity to the emerging telehealth markets.
A potentially considerable value driver is that WHSI’s iHelp Max 4G platform opens the door to the massive opportunities inherent in the developing telehealth market. While already an enormous market, telehealth is expected to explode higher in the coming years, especially after the COVID pandemic initiated millions of patients to the ease and value of telehealth solutions.
Notably, the next wave of adoption isn’t slowing. On the contrary, with insurance providers and physician offices pushing to make telehealth more mainstream, noting that it’s cost-effective, more efficient, and can, in most cases, accomplish the same as an office visit, the telehealth market is a multi-billion dollar segment in the making. Making sure its devices fit into the movement validates the durability of its devices long term.
Multiple Revenue-Generating Initiatives In-Play
Still, telehealth is just another one of the massive opportunities in the WHSI sights. They are also finding their footing in the billion-dollar medical alarm device and eHealth sector by providing products and services for healthcare applications and further developing solutions for payment, M Internet of Things (IoT), and healthcare applications. That’s not all.
WHSI is also capitalizing on its experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, and sensor technologies to bring more products to the markets. And leveraging managerial expertise and a formidable development pipeline should allow WHSI to compete effectively in those markets as well. Monetizing those ambitions further exposes an investment proposition and opportunity that may be simply too compelling to ignore at penny prices.
A Breakout In 2022…Likely
Indeed, the sum of WHSI’s parts shows that the stock is appreciably undervalued at current prices. However, it doesn’t show that WHSI is a company in hypergrowth that is taking the right steps at the right time to position itself for potentially exponential growth in 2022 and 2023. Knowing the latter makes WHSI ripe for investment consideration and, at just $0.014, makes the case compelling.
Thus, while WHSI stock has been in rally mode, it deserves more to the upside. That bullish presumption is based on a totality of assets and a team taking demonstrable steps to monetize its assets and take advantage of a surging market opportunity. Keep in mind that those following or already invested in WHSI know that moves in the stock can happen quickly. They also should know that with WHSI more potent today than when its stock traded about 214% higher in April, a return to 52-week highs is indeed in play.
Hence, positioned for exponential growth in 2022 and beyond, attraction to the value proposition offered by WHSI stock is both warranted and timely. So, don’t evaluate the strength of WHSI by its current price but rather by its ability and as a low-priced investment opportunity providing exposure to a massive wearable medical device market. And with even the most conservative estimates of the wearables market amounting to hundreds of millions in revenue opportunity, being in the game is a wise consideration. Wearable Health Solutions, Inc. could be that conduit.
Disclaimers: Shore Thing Media, LLC. (STM, Llc.) is responsible for the production and distribution of this content. STM, Llc. is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by STM, Llc. is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall STM, Llc. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by STM, Llc., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. STM, Llc. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, STM, Llc., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. STM, LLC has been compensated up to ten-thousand-dollars cash via wire transfer to produce and syndicate content for Wearable Health Solutions, Inc. for a period of one month. Please read the full disclaimer at https://primetimeprofiles.com/
As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
